Search Results - "Bebb, G"

Current landscape of immunotherapy in the treatment of solid tumours, with future opportunities and challenges by Nixon, N A, Blais, N, Ernst, S, Kollmannsberger, C, Bebb, G, Butler, M, Smylie, M, Verma, S

“…Immunotherapy has emerged as a new standard of care, showing survival benefit for solid tumours in multiple disease sites and indications. The survival…”
Get full text

Exercise preferences, levels and quality of life in lung cancer survivors by Leach, H. J., Devonish, J. A., Bebb, D. G., Krenz, K. A., Culos-Reed, S. N.

“…Purpose Lung cancer poses multiple challenges to adopting an exercise (EX) program, and the ideal timing of an EX program to improve quality of life (QoL) is…”
Get full text

The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status by Kim, M, Williamson, C T, Prudhomme, J, Bebb, D G, Riabowol, K, Lee, P W K, Lees-Miller, S P, Mori, Y, Rahman, M M, McFadden, G, Johnston, R N

“…Replication-competent oncolytic viruses hold great potential for the clinical treatment of many cancers. Importantly, many oncolytic virus candidates, such as…”
Get full text

A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes by Ahmed, S, Barbera, L, Bartlett, S J, Bebb, D G, Brundage, M, Bryan, S, Cheung, W Y, Coburn, N, Crump, T, Cuthbertson, L, Howell, D, Klassen, A F, Leduc, S, Li, M, Mayo, N E, McKinnon, G, Olson, R, Pink, J, Robinson, J W, Santana, M J, Sawatzky, R, Moxam, R S, Sinclair, S, Servidio-Italiano, F, Temple, W

“…Patient-reported outcomes (pros) are essential to capture the patient's perspective and to influence care. Although pros and pro measures are known to have…”
Get full text

Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy by Ho, C.K, Kornaga, E.N, Klimowicz, A.C, Enwere, E.K, Dean, M, Bebb, G.D, Phan, T, Ghatage, P, Magliocco, A.M, Lees-Miller, S.P, Doll, C.M

“…Abstract Objective The management of locally advanced cervical cancer has improved significantly with the advent of cisplatin-based chemoradiotherapy (CRT) as…”
Get full text

Shame, guilt, and communication in lung cancer patients and their partners by Dirkse, D, Lamont, L, Li, Y, Simonič, A, Bebb, G, Giese-Davis, J

“…Lung cancer patients report the highest distress levels of all cancer groups. In addition to poor prognosis, the self-blame and stigma associated with smoking…”
Get full text

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers by Au, NHC, Cheang, M, Huntsman, DG, Yorida, E, Coldman, A, Elliott, WM, Bebb, G, Flint, J, English, J, Gilks, CB, Grimes, HL

“…This study has investigated a panel of immunomarkers in non‐small cell lung carcinoma (NSCLC). Unsupervised hierarchical clustering analysis was used to…”
Get full text

Oncoplastic Surgery and Radiation Therapy for Breast Conservation: Patient- and Physician-reported Outcomes by Maguire, P.D, Adams, A, Bebb, G, Kays, C, Nichols, M

Get full text

Expression of DNA Damage Response Proteins in Cervical Cancer Patients Treated With Radical Chemoradiation Therapy by Ho, C.K, Kornaga, E, Klimowicz, A, Dean, M, Bebb, G, Phan, T, Ghatage, P, Magliocco, A.M, Lees-Miller, S.P, Doll, C.M

Get full text

The Broad Application of Prepectoral Direct-to-Implant Breast Reconstruction with Acellular Dermal Matrix Drape and Fluorescent Imaging in a Community Setting by Bilezikian, Jordan A., Tenzel, Paul L., Bebb, Gregory G., Kays, Charles R.

“…Much has been written regarding the new paradigm of prepectoral direct-to-implant reconstruction, but patient selection continues to be unclear. Prepectoral…”
Get full text

Concurrent and Adjuvant Nimotuzumab Combined with Palliative Thoracic Radiation for Patients with Stage IIb/III/IV Non-small Cell Lung Cancer: A Phase I Study by Brade, A.M, Bebb, G, Smith, C, Rorke, S, Sherman, I

Get full text

Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer by Elegbede, Anifat A., Gibson, Amanda J., Fu, Hao, Dean, Michelle L., Ezeife, Doreen A., Lau, Harold, Cheung, Winson Y., Bebb, Dafydd G.

“…The authors sought to quantify the treatment patterns and outcomes for limited-stage (LS) and extensive-stage (ES) small cell lung cancer (SCLC) in a…”
Get full text

ATM loss in NSCLC increases sensitivity to cisplatin and PARP inhibition by Bebb, D G, Petersen, L F, Moore, J, Elegbede, A, Lees-Miller, S

Get full text

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer by BEBB, D. G, YU, Z, CHEN, J, TELATAR, M, GELMON, K, PHILLIPS, N, GATTI, R. A, GLICKMAN, B. W

“…Epidemiological evidence points to an increased risk of breast cancer in ataxia telangiectasia (AT) heterozygote women. Previous attempts to screen early onset…”
Get full text

Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011 by Ko, J J, Tudor, R, Li, H, Liu, M, Skolnik, K, Boland, W Kells, Macklow, J, Morris, D, Bebb, D G

“…Only approximately 25% of stage iv non-small-cell lung cancer (nsclc) patients receive systemic therapy. For such patients, we examined factors affecting…”
Get full text

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective by Bebb, D G, Agulnik, J, Albadine, R, Banerji, S, Bigras, G, Butts, C, Couture, C, Cutz, J C, Desmeules, P, Ionescu, D N, Leighl, N B, Melosky, B, Morzycki, W, Rashid-Kolvear, F, Lab, Clin, Sekhon, H S, Smith, A C, Stockley, T L, Torlakovic, E, Xu, Z, Tsao, M S

“…The ros1 kinase is an oncogenic driver in non-small-cell lung cancer (nsclc). Fusion events involving the gene are found in 1%-2% of nsclc patients and lead to…”
Get full text

Canadian perspectives: update on inhibition of ALK -positive tumours in advanced non-small-cell lung cancer by Melosky, B, Cheema, P, Agulnik, J, Albadine, R, Bebb, D G, Blais, N, Burkes, R, Butts, C, Card, P B, Chan, A M Y, Hirsh, V, Ionescu, D N, Juergens, R, Morzycki, W, Poonja, Z, Sangha, R, Tehfe, M, Tsao, M S, Vincent, M, Xu, Z, Liu, G

“…Inhibition of the anaplastic lymphoma kinase (alk) oncogenic driver in advanced non-small-cell lung carcinoma (nsclc) improves survival. In 2015, Canadian…”
Get full text

1099 Influence of CXCR4 localization on in vitro migration of non small cell lung cancer cell lines and on clinical outcome in NSCLC by Otsuka, S, Muzik, H, Stolte, E, Boland, W, Klimowicz, A, Konno, M, Morris, D, Magliocco, T, Bebb, G

Get full text

Mediastinal germ cell tumor in a child with precocious puberty and Klinefelter syndrome by Bebb, Gregory G, Grannis, Frederic W, Paz, Isaac B, Slovak, Marilyn L, Chilcote, Robert

“…An 8-year-old boy presented with precocious puberty and a mediastinal mass. A computer search showed that this rare presentation is most common with germ cell…”
Get full text

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer by Melosky, B, Agulnik, J, Albadine, R, Banerji, S, Bebb, D G, Bethune, D, Blais, N, Butts, C, Cheema, P, Cheung, P, Cohen, V, Deschenes, J, Ionescu, D N, Juergens, R, Kamel-Reid, S, Laurie, S A, Liu, G, Morzycki, W, Tsao, M S, Xu, Z, Hirsh, V

“…Anaplastic lymphoma kinase (alk) is an oncogenic driver in non-small-cell lung cancer (nsclc). Chromosomal rearrangements involving the ALK gene occur in up to…”
Get full text